- •Apothecary
- •History
- •Other Mentions In Creative Literature
- •Noted Apothecaries
- •See also
- •References
- •Overview
- •Etymology
- •Function
- •Examples
- •See also
- •References
- •Clinical pharmacy
- •[Edit] See also
- •[Edit] References
- •[Edit] External links
- •Compounding
- •History
- •New England Compounding Center incident
- •Roles During research and development
- •Patients with unique or unusual medication needs
- •Personalized medicine and polypharmacy
- •Recent trends
- •Regulation in the United States
- •Analogy to "off-label" use
- •Drug testing and reporting of incidents
- •Criticism
- •Regulation in Australia
- •See also
- •References
- •External links
- •Consultant pharmacist
- •United States
- •United Kingdom
- •See also
- •External links
- •Etymology
- •Medication
- •Spiritual and religious use
- •Self-improvement
- •Recreational drug use
- •Administering drugs
- •See also
- •References
- •Health care
- •Health care delivery
- •Primary care
- •Secondary Care
- •Tertiary care
- •Quaternary care
- •Home and community care
- •Related sectors
- •Health system
- •Health care industry
- •Health care research
- •Health care financing
- •Health care administration and regulation
- •Health information technology
- •See also
- •Herbalism
- •History
- •Ancient times
- •Middle Ages
- •Early modern era
- •Modern herbal medicine
- •Biological background
- •Clinical tests
- •Prevalence of use
- •Herbal preparations
- •Practitioners
- •Government regulations
- •Traditional herbal medicine systems
- •Herbal philosophy and spiritual practices
- •Uses of herbal medicines by animals
- •Extinction of medicinal plant species
- •See also
- •References
- •Further reading
- •History of pharmacy
- •Prehistoric pharmacy
- •Antiquity
- •Middle Ages
- •See also
- •References
- •Hospice
- •History Early development
- •Rise of the modern hospice movement
- •Hospice care
- •North America Canada
- •United States
- •United Kingdom
- •Other nations
- •See also
- •Further reading
- •External links
- •Hospital pharmacy
- •Sterile production
- •See also
- •External links
- •Hospital
- •Etymology
- •General
- •District
- •Specialized
- •Teaching
- •Clinics
- •Departments
- •History Early examples
- •Roman Empire
- •Medieval Islamic world
- •Medieval Europe
- •Colonial America
- •Modern era
- •Criticism
- •Funding
- •Buildings Architecture
- •See also
- •References
- •Bibliography
- •External links
- •Medical education
- •Entry-level education
- •Postgraduate education
- •Continuing medical education
- •Online learning
- •Example of medical education systems
- •Medical Education Journals
- •See also
- •References
- •External links
- •Medical ethics
- •History
- •Values in medical ethics
- •Autonomy
- •Beneficence
- •Non-Maleficence
- •Double effect
- •Conflicts between autonomy and beneficence/non-maleficence
- •Euthanasia
- •Informed consent
- •Confidentiality
- •Criticisms of orthodox medical ethics
- •Importance of communication
- •Control and resolution
- •Guidelines
- •Ethics committees
- •Medical ethics in an online world
- •Cultural concerns
- •Truth-telling
- •Online business practices
- •Conflicts of interest
- •Referral
- •Vendor relationships
- •Treatment of family members
- •Sexual relationships
- •Futility
- •Sources and references
- •External links
- •Medical psychology
- •Behavioral medicine
- •Certifications
- •References
- •See also
- •External links
- •Institutions
- •Branches
- •Basic sciences
- •'Medicine' as a specialty
- •Diagnostic specialties
- •Other major specialties
- •Interdisciplinary fields
- •Education
- •Medical ethics
- •Legal controls
- •Criticism of modern medicine
- •Honors and awards
- •History
- •Ancient world
- •Middle ages
- •Patron saints
- •Nobel Prize in Physiology or Medicine
- •Background
- •Nomination and selection
- •Diplomas
- •Award money
- •Ceremony and banquet
- •Laureates
- •Time factor and death
- •Controversial inclusions and exclusions
- •Limits on number of awardees
- •Years without awards
- •References
- •Bibliography
- •[Edit] External links
- •Online pharmacy
- •Home delivery
- •Risks and concerns
- •Discussion
- •International consumers
- •U.S. Consumers
- •Overseas online pharmacies and u.S. Law
- •Enforcement
- •Mail fraud
- •Uk consumers
- •See also
- •References
- •External links
- •Pharmacist
- •Nature of the work
- •Education and credentialing
- •Practice specialization
- •Training and practice by country
- •Australia
- •Japan History
- •Contemporary
- •Tanzania
- •United Kingdom
- •Education and registration
- •Vietnam
- •United States
- •Pharmacy School Accreditation
- •Education
- •Specialization and credentialing
- •Earnings and wages
- •Noted people who were pharmacists
- •See also
- •References
- •Further reading
- •External links
- •Pharmacognosy
- •Introduction
- •Issues in phytotherapy
- •Constituents and drug synergysm
- •Herb and drug interactions
- •Natural products chemistry
- •Loss of biodiversity
- •Sustainable sources of plant and animal drugs
- •Acceptance in the United States
- •External links
- •References
- •Pharmacology
- •Divisions
- •Environmental pharmacology
- •Scientific background
- •Medicine development and safety testing
- •Drug legislation and safety
- •Education
- •See also
- •Footnotes
- •[Edit] External links
- •Pharmacopoeia
- •Etymology
- •History
- •City pharmacopoeia
- •National pharmacopoeia
- •International pharmacopoeia
- •Medical preparations, uses and dosages
- •See also
- •References
- •External links
- •Pharmacy automation
- •History
- •Chronology
- •Global variations
- •Current state of the industry
- •Technological changes and design improvements
- •Other pharmacy-dispensing concerns besides counting
- •Future development
- •Liquid Oral doses (Childs, aging, oncology...)
- •Repackaging process and stability data
- •See also
- •References
- •External links
- •Videos of robots in action
- •Pharmacy technician
- •See also
- •References
- •External links
- •Pharmacy
- •Disciplines
- •Professionals
- •Pharmacists
- •Pharmacy technicians
- •History
- •Types of pharmacy practice areas
- •Community pharmacy
- •Hospital pharmacy
- •Clinical pharmacy
- •Ambulatory care pharmacy
- •Compounding pharmacy
- •Consultant pharmacy
- •Internet pharmacy
- •Veterinary pharmacy
- •Nuclear pharmacy
- •Military pharmacy
- •Pharmacy informatics
- •Issues in pharmacy Separation of prescribing from dispensing
- •The future of pharmacy
- •Pharmacy journals
- •See also
- •Symbols
- •References
- •External links
- •Philosophy of healthcare
- •Ethics of healthcare
- •Medical ethics
- •Nursing ethics
- •Business ethics
- •Political philosophy of healthcare
- •Patients' Bill of Rights
- •Health insurance
- •Research and scholarship
- •Clinical trials
- •Quality assurance
- •Birth and death Reproductive rights
- •Birth and living
- •Death and dying
- •Role development
- •See also
- •References
- •External links
Sustainable sources of plant and animal drugs
As species face loss of habitat or overharvesting, there have been new issues to deal with in sourcing crude drugs. These include changes to the herb from farming practices, substitution of species or other plants altogether, adulteration and cross-pollination issues[citation needed]. For instance, ginseng which is field farmed may have significant problems with fungus, making contamination with fungicides an issue.[citation needed] This may be remedied with woods grown programs, but they are insufficient to produce enough ginseng to meet demand.[citation needed] The wildcrafted echinacea, black cohosh and American ginseng often rely upon old growth root, often in excess of 50 years of age and it is not clear that younger stock will have the same pharmaceutical effect.[14] Black cohosh may be adulterated with the related Chinese actea species, which is not the same. Ginseng may be replaced by ginseniodes from Jiaogulan which has been stated to have a different effect than the full panax root.[15]
The problem may be exacerbated by the growth of pills and capsules as the preferred method of ingesting medication as they are cheaper and more available than traditional, individually tailored prescriptions of raw medicinals but the contents are harder to track.[citation needed] Seahorses are a case in point: Seahorses once had to be of a certain size and quality before they were accepted by practitioners and consumers.[citation needed] But declining availability of the preferred large, pale and smooth seahorses has been offset by the shift towards prepackaged medicines, which make it possible for TCM merchants to sell previously unused juvenile, spiny and dark-coloured animals.[citation needed] Today almost a third of the seahorses sold in China are prepackaged. [16]
The farming of plant or animal species for medicinal purposes has caused difficulties. Rob Parry Jones andAmanda Vincentwrite:
One solution is to farm medicinal animals and plants. Chinese officials have promoted this as a way of guaranteeing supplies as well as protecting endangered species. And there have been some successes—notably with plant species, such as American ginseng—which is used as a general tonic and for chronic coughs. Red deer, too, have for centuries been farmed for their antlers, which are used to treat impotence and general fatigue. But growing your own is not a universal panacea. Some plants grow so slowly that cultivation in not economically viable. Animals such as musk deer may be difficult to farm, and so generate little profit. Seahorses are difficult to feed and plagued by disease in captivity. Other species cannot be cultivated at all. Even when it works, farming usually fails to match the scale of demand. Overall, cultivated TCM plants in China supply less than 20 per cent of the required 1.6 million tonnes per annum. Similarly, China's demand for animal products such as musk and pangolin scales far exceeds supply from captive-bred sources.
Farming alone can never resolve conservation concerns, as government authorities and those who use Chinese medicine realise. For a start, consumers often prefer ingredients taken from the wild, believing them to be more potent. This is reflected in the price, with wild oriental ginseng fetching up to 32 times as much as cultivated plants. Then there are welfare concerns. Bear farming in China is particularly controversial. Around 7600 captive bears have their bile "milked" through tubes inserted into their gall bladders. The World Society for the Protection of Animals states that bear farming is surrounded by "appalling levels of cruelty and neglect".[17] Chinese officials state that 10,000 wild bears would need to be killed each year to produce as much bile, making bear farming the more desirable option. The World society for the Protection of Animals, however, states that "it is commonly believed in China that the bile from a wild bear is the most potent, and so farming bears for their bile cannot replace the demand for the product extracted from wild animals".
One alternative to farming involves replacing medical ingredients from threatened species with manufactured chemical compounds. In general, this sort of substitution is difficult to achieve because the active ingredient is often not known. In addition, most TCM users believe that TCM compounds may act synergistically so several ingredients may interact to give the required effect. Thus TCM users often people prefer the wild source. Tauro ursodeoxycholic acid, the active ingredient of bear bile, can be synthesised and is used by some Western doctors to treat gallstones, but many TCM consumers reject it as being inferior to the natural substance from wild animals.[16]